Cargando…

MT-CYB mutations in hypertrophic cardiomyopathy

Mitochondrial dysfunction is a characteristic of heart failure. Mutations in mitochondrial DNA, particularly in MT-CYB coding for cytochrome B in complex III (CIII), have been associated with isolated hypertrophic cardiomyopathy (HCM). We hypothesized that MT-CYB mutations might play an important ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagen, Christian M, Aidt, Frederik H, Havndrup, Ole, Hedley, Paula L, Jespersgaard, Cathrine, Jensen, Morten, Kanters, Jørgen K, Moolman-Smook, Johanna C, Møller, Daniel V, Bundgaard, Henning, Christiansen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893158/
https://www.ncbi.nlm.nih.gov/pubmed/24498601
http://dx.doi.org/10.1002/mgg3.5
_version_ 1782299631350185984
author Hagen, Christian M
Aidt, Frederik H
Havndrup, Ole
Hedley, Paula L
Jespersgaard, Cathrine
Jensen, Morten
Kanters, Jørgen K
Moolman-Smook, Johanna C
Møller, Daniel V
Bundgaard, Henning
Christiansen, Michael
author_facet Hagen, Christian M
Aidt, Frederik H
Havndrup, Ole
Hedley, Paula L
Jespersgaard, Cathrine
Jensen, Morten
Kanters, Jørgen K
Moolman-Smook, Johanna C
Møller, Daniel V
Bundgaard, Henning
Christiansen, Michael
author_sort Hagen, Christian M
collection PubMed
description Mitochondrial dysfunction is a characteristic of heart failure. Mutations in mitochondrial DNA, particularly in MT-CYB coding for cytochrome B in complex III (CIII), have been associated with isolated hypertrophic cardiomyopathy (HCM). We hypothesized that MT-CYB mutations might play an important causal or modifying role in HCM. The MT-CYB gene was sequenced from DNA isolated from blood from 91 Danish HCM probands. Nonsynonymous variants were analyzed by bioinformatics, molecular modeling and simulation. Two germline-inherited, putative disease-causing, nonsynonymous variants: m.15024G>A; p.C93Y and m.15482T>C; p.S246P were identified. Modeling showed that the p.C93Y mutation leads to disruption of the tertiary structure of Cytb by helix displacement, interfering with protein–heme interaction. The p.S246P mutation induces a diproline structure, which alters local secondary structure and induces a kink in the protein backbone, interfering with macromolecular interactions. These molecular effects are compatible with a leaky phenotype, that is, limited but progressive mitochondrial dysfunction. In conclusion, we find that rare, putative leaky mtDNA variants in MT-CYB can be identified in a cohort of HCM patients. We propose that further patients with HCM should be examined for mutations in MT-CYB in order to clarify the role of these variants.
format Online
Article
Text
id pubmed-3893158
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-38931582014-02-04 MT-CYB mutations in hypertrophic cardiomyopathy Hagen, Christian M Aidt, Frederik H Havndrup, Ole Hedley, Paula L Jespersgaard, Cathrine Jensen, Morten Kanters, Jørgen K Moolman-Smook, Johanna C Møller, Daniel V Bundgaard, Henning Christiansen, Michael Mol Genet Genomic Med Original Articles Mitochondrial dysfunction is a characteristic of heart failure. Mutations in mitochondrial DNA, particularly in MT-CYB coding for cytochrome B in complex III (CIII), have been associated with isolated hypertrophic cardiomyopathy (HCM). We hypothesized that MT-CYB mutations might play an important causal or modifying role in HCM. The MT-CYB gene was sequenced from DNA isolated from blood from 91 Danish HCM probands. Nonsynonymous variants were analyzed by bioinformatics, molecular modeling and simulation. Two germline-inherited, putative disease-causing, nonsynonymous variants: m.15024G>A; p.C93Y and m.15482T>C; p.S246P were identified. Modeling showed that the p.C93Y mutation leads to disruption of the tertiary structure of Cytb by helix displacement, interfering with protein–heme interaction. The p.S246P mutation induces a diproline structure, which alters local secondary structure and induces a kink in the protein backbone, interfering with macromolecular interactions. These molecular effects are compatible with a leaky phenotype, that is, limited but progressive mitochondrial dysfunction. In conclusion, we find that rare, putative leaky mtDNA variants in MT-CYB can be identified in a cohort of HCM patients. We propose that further patients with HCM should be examined for mutations in MT-CYB in order to clarify the role of these variants. Blackwell Publishing Ltd 2013-05 2013-04-12 /pmc/articles/PMC3893158/ /pubmed/24498601 http://dx.doi.org/10.1002/mgg3.5 Text en © 2013 Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Articles
Hagen, Christian M
Aidt, Frederik H
Havndrup, Ole
Hedley, Paula L
Jespersgaard, Cathrine
Jensen, Morten
Kanters, Jørgen K
Moolman-Smook, Johanna C
Møller, Daniel V
Bundgaard, Henning
Christiansen, Michael
MT-CYB mutations in hypertrophic cardiomyopathy
title MT-CYB mutations in hypertrophic cardiomyopathy
title_full MT-CYB mutations in hypertrophic cardiomyopathy
title_fullStr MT-CYB mutations in hypertrophic cardiomyopathy
title_full_unstemmed MT-CYB mutations in hypertrophic cardiomyopathy
title_short MT-CYB mutations in hypertrophic cardiomyopathy
title_sort mt-cyb mutations in hypertrophic cardiomyopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893158/
https://www.ncbi.nlm.nih.gov/pubmed/24498601
http://dx.doi.org/10.1002/mgg3.5
work_keys_str_mv AT hagenchristianm mtcybmutationsinhypertrophiccardiomyopathy
AT aidtfrederikh mtcybmutationsinhypertrophiccardiomyopathy
AT havndrupole mtcybmutationsinhypertrophiccardiomyopathy
AT hedleypaulal mtcybmutationsinhypertrophiccardiomyopathy
AT jespersgaardcathrine mtcybmutationsinhypertrophiccardiomyopathy
AT jensenmorten mtcybmutationsinhypertrophiccardiomyopathy
AT kantersjørgenk mtcybmutationsinhypertrophiccardiomyopathy
AT moolmansmookjohannac mtcybmutationsinhypertrophiccardiomyopathy
AT møllerdanielv mtcybmutationsinhypertrophiccardiomyopathy
AT bundgaardhenning mtcybmutationsinhypertrophiccardiomyopathy
AT christiansenmichael mtcybmutationsinhypertrophiccardiomyopathy